A strawberry cervix is a pattern of tiny red dots scattered across the surface of the cervix, caused by pinpoint bleeding from capillaries just beneath the tissue. The appearance looks strikingly like the surface of a strawberry, and it is considered a near-certain visual marker of infection with the parasite Trichomonas vaginalis. Despite its strong diagnostic value, it shows up on routine examination in only a small fraction of infected women, which means most cases of trichomoniasis are caught by other means entirely.
What Creates the Strawberry Appearance
The red dots are punctate hemorrhages, meaning very small areas where blood has leaked from tiny blood vessels in the cervical tissue. Trichomonas vaginalis is a single-celled parasite that attaches to the surface of the vaginal and cervical lining. Once attached, it triggers a strong inflammatory response. The parasite’s interaction with cervical cells ramps up the production of several inflammatory signaling molecules, including IL-8, IL-1α, IL-1β, and vascular endothelial growth factor, all of which play roles in inflammation and blood vessel behavior.1PLoS ONE. The Pathogenesis of Human Cervical Epithelium Cells Induced by Interacting with Trichomonas vaginalis That inflammatory cascade damages the thin capillaries in the cervix, producing the scattered spots of bleeding visible on exam. The cervix can also become swollen and tender, but it is specifically the dotted hemorrhage pattern that earns the strawberry label.
The medical term for this finding is colpitis macularis. “Colpitis” refers to inflammation of the vagina or cervix, and “macularis” describes the spotted appearance. You might see this term in medical literature or on a pathology report, but it describes the same thing: a speckled, reddened cervix caused by micro-bleeding at the surface.
How Common It Is and Why Clinicians Still Watch for It
On a standard pelvic exam without magnification, strawberry cervix shows up in roughly 2% of women who have trichomoniasis.2Archives of Obstetrics and Gynaecology. Strawberry Cervix- A Clinical Image of Trichomonas vaginalis: A Case Report – Section: Discussion That is a strikingly low number, and it means a clinician who relies on seeing this sign will miss the vast majority of infections. A systematic review for the U.S. Preventive Services Task Force put the sensitivity of detecting strawberry cervix on gross examination at just 1.7%, meaning fewer than 2 in 100 women with trichomoniasis will show the sign to the naked eye during a routine exam.3JAMA. Periodic Screening Pelvic Examination: Evidence Report and Systematic Review for the US Preventive Services Task Force – Section: Trichomoniasis
What makes strawberry cervix diagnostically interesting despite its rarity is its specificity. That same review found the specificity was 100%, meaning that when it was seen, it was always caused by Trichomonas.4JAMA. Periodic Screening Pelvic Examination: Evidence Report and Systematic Review for the US Preventive Services Task Force – Section: Trichomoniasis In practical terms, if a clinician spots the classic strawberry pattern during an exam, trichomoniasis can be diagnosed on the spot with very high confidence. The problem is that the absence of the sign tells you almost nothing. It is one of those rare diagnostic findings that is extremely useful when present but nearly useless when absent.
With colposcopy, a magnified examination of the cervix, the detection rate of the spotted pattern climbs substantially. But colposcopy is not a routine part of a standard gynecological visit, so for most women the finding either jumps out during a regular speculum exam or it does not.
How Trichomoniasis Is Actually Diagnosed
Because strawberry cervix is visible in so few cases, clinicians rely on laboratory tests. Historically, wet mount microscopy was the go-to: a sample of vaginal discharge is placed on a slide with a drop of saline, and a clinician looks for the motile, pear-shaped parasites swimming around. Wet mount is fast and cheap but misses a lot of infections because the parasites die quickly once removed from the body, and the test depends on operator skill.
Nucleic acid amplification tests have largely replaced wet mount as the preferred diagnostic method. These molecular tests detect the parasite’s DNA and are far more sensitive than looking under a microscope.5Elsevier / Biosensors and Bioelectronics. A molecular-beacon-based asymmetric PCR assay for easy visualization of amplicons in the diagnosis of trichomoniasis Rapid antigen tests are also available for point-of-care use in clinics, offering results in minutes rather than days. The shift toward molecular testing has improved detection considerably, which matters because trichomoniasis is one of the most common curable sexually transmitted infections worldwide, and missed cases contribute to ongoing transmission.
Symptoms Beyond the Cervix
Trichomoniasis does not always announce itself. A large proportion of infected women have no symptoms at all, and among those who do, the symptoms overlap with other vaginal infections. The classic presentation includes a frothy, yellowish-green vaginal discharge with an unpleasant odor, along with itching, burning, or soreness in the genital area. Some women notice pain during urination or sex. The vaginal pH typically rises above 4.5, which is higher than normal.
In men, trichomoniasis is even more likely to be silent. When symptoms do appear, they usually involve urethral discharge or irritation during urination. The infection can persist for months or years without treatment in both sexes, serving as a quiet reservoir for ongoing transmission.
Treatment and the Challenge of Reinfection
The standard treatment for trichomoniasis is oral metronidazole or tinidazole, both of which are effective against the parasite.6PubMed. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations A single large dose or a week-long course can clear the infection in most people. These medications work by damaging the parasite’s DNA, and they have been the backbone of trichomoniasis treatment for decades.
The tricky part is reinfection. Up to 70% of male sexual partners of infected women are themselves carrying the parasite, and if only one partner is treated, the infection bounces back once sexual activity resumes.7PubMed Central. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity Partner treatment is essential for breaking the cycle, and guidelines recommend rescreening treated women at three months because repeat infection rates are high.8PubMed Central. Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivity A Cochrane review confirmed that treating partners reduces longer-term reinfection rates.9PubMed Central. Interventions for treating trichomoniasis in women
One practical barrier is that many male partners are asymptomatic and resist the idea that they need treatment. Expedited partner therapy, where the clinician provides a prescription or medication for the partner without requiring a separate visit, has been used to address this, though its availability depends on local regulations.
When Standard Treatment Fails
Most cases respond well to metronidazole or tinidazole, but at least 5% of clinical trichomoniasis cases involve parasites that are resistant to metronidazole.10PubMed Central. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis Resistance is usually partial rather than absolute, meaning that higher doses or longer courses can sometimes overcome it. Tinidazole tends to perform better than metronidazole against moderately resistant strains because it reaches higher concentrations in vaginal tissue.
For women with persistent infections despite repeated standard therapy, clinicians sometimes try prolonged high-dose regimens, intravaginal approaches, or combinations of oral and topical medications. True treatment failure requiring these escalation strategies is uncommon but can be frustrating for the patients who experience it, as the infection can drag on for months. Research into alternative agents is ongoing, though no new drug class has replaced the nitroimidazoles as a frontline option.
Trichomoniasis During Pregnancy
Trichomoniasis during pregnancy carries risks that go beyond discomfort. A systematic review and meta-analysis found that infection was linked to an increased chance of preterm delivery, with odds roughly 27% higher than in uninfected women. The same analysis found that pre-labor rupture of membranes was about 87% more likely, and the odds of delivering a low-birth-weight baby were roughly doubled.11PubMed Central. Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis An earlier large study similarly found that vaginal Trichomonas infection at mid-pregnancy was tied to both low birth weight and preterm delivery.12PubMed. Trichomonas vaginalis associated with low birth weight and preterm delivery
These associations make screening and treatment during pregnancy a matter of real clinical concern. The standard medications can be used in pregnancy, though the timing and approach require clinical judgment. The inflammatory environment created by the parasite is thought to contribute to the adverse outcomes, which is why prompt treatment is considered important even when symptoms are mild or absent.
The HIV Connection
Trichomoniasis has a well-documented relationship with HIV. The parasite causes microscopic damage and inflammation in the genital lining, which creates easier entry points for other infections. There is strong evidence that Trichomonas increases both the transmission and acquisition of HIV in women, and that successful treatment for trichomoniasis can reduce how much HIV is shed in genital secretions.13BMJ Journals. Trichomoniasis and HIV interactions: a review This bidirectional interaction is one reason public health experts consider trichomoniasis more than a nuisance infection. In regions with high rates of both infections, controlling trichomoniasis has been discussed as a strategy for reducing HIV spread.
The inflammatory response triggered by the parasite, the same one responsible for the strawberry cervix appearance, plays a central role here. Inflammation recruits immune cells to the cervical and vaginal tissue, and some of those immune cells are the very ones that HIV targets. The disrupted tissue barrier and the concentration of susceptible cells together create conditions favorable for HIV infection.
How the Parasite Interacts with Vaginal Bacteria
Trichomoniasis does not exist in isolation inside the vaginal ecosystem. Research has shown that Trichomonas vaginalis and bacteria associated with bacterial vaginosis can engage in cooperative metabolic interactions. In laboratory conditions where neither could grow alone, the parasite and certain dysbiotic vaginal bacteria supported each other’s growth, suggesting a mutualistic relationship.14PLOS Pathogens. Metabolic cooperation supports mutual growth between the protozoan parasite Trichomonas vaginalis and dysbiotic vaginal bacteria
This finding helps explain why trichomoniasis and bacterial vaginosis so often occur together. The two conditions share symptoms like abnormal discharge and elevated vaginal pH, and they may actively make each other more likely. A healthy vaginal microbiome dominated by Lactobacillus species maintains an acidic environment that is hostile to many pathogens. When that balance shifts toward the bacteria associated with bacterial vaginosis, the resulting environment appears more hospitable to Trichomonas, and the parasite may in turn reinforce the bacterial imbalance. For clinicians, this means treating trichomoniasis alone may not fully resolve a patient’s symptoms if concurrent bacterial vaginosis is also present.
Why Trichomoniasis Gets Less Attention Than It Deserves
Trichomoniasis is estimated to affect hundreds of millions of people worldwide each year, making it the most common curable sexually transmitted infection. Yet it receives far less research funding and public attention than infections like chlamydia, gonorrhea, or syphilis. Part of this is perception: because the parasite is not a bacterium or virus, it falls into a gap between the disciplines that study STIs. It is rarely fatal on its own, so it lacks the urgency that drives funding for more dangerous pathogens. And because so many cases are asymptomatic, many people never know they have it, which reduces public demand for attention.
The consequences of this neglect are real. Screening guidelines for trichomoniasis are less standardized than for other STIs, and routine screening is not universally recommended outside of specific high-risk populations. Many clinics do not stock the newer molecular tests, relying instead on less sensitive methods. The result is a large pool of undiagnosed, untreated infections that quietly contribute to adverse pregnancy outcomes, increased HIV risk, and ongoing transmission. Strawberry cervix, when it is spotted, can be a clinical wake-up call, but the infection’s overall low profile means that many opportunities for diagnosis are missed long before anyone looks at the cervix.
Can Other Conditions Mimic a Strawberry Cervix
Although the data on specificity suggest that a true strawberry cervix pattern is essentially diagnostic of trichomoniasis, cervical redness and irritation can have other causes that might be confused with it on a quick visual exam. Cervicitis caused by chlamydia or gonorrhea can produce a red, inflamed cervix, but the pattern is usually diffuse rather than stippled. Contact irritation from douching, spermicides, or allergic reactions can also redden the cervix. And cervical ectropion, where the cells from inside the cervical canal are visible on the outer surface, creates a red appearance that is normal and not pathological at all.
The key distinguishing feature of the strawberry cervix is the discrete, scattered, punctate pattern, which looks meaningfully different from a uniformly inflamed or irritated cervix once you know what to look for. Clinicians trained to recognize the pattern can differentiate it from these mimics, but in ambiguous cases, laboratory confirmation with a test for Trichomonas is the most reliable way to settle the question. In practice, any cervix that looks abnormal during an exam will prompt testing rather than a clinical guess, which is the right approach regardless of what the pattern suggests.